Pharmaceutcals

Politics By Nicholas Florko

Biden’s new Covid plan: more boosters, free home testing, and ‘monoclonal antibody strike teams’

First Opinion By Jeffrey E. Harris

The Fifth Circuit Court got the science wrong on OSHA’s vaccination mandate

First Opinion By Kate M. Nicholson

Another fight for Covid long-haulers: having their pain acknowledged

Health Tech By Katie Palmer

Artificial intelligence is making a pitch to transform radiology. Will it pay off for hospitals?

Health By Helen Branswell

Some experts suggest Omicron variant may have evolved in an animal host

In the Lab By Angus Chen

Liquid biopsies could help screen for countless cancers. But who should get them?

Pharmalot By Ed Silverman

Amgen joins a growing list of drug makers cutting discounts to safety-net hospitals

Health By Andrew Joseph

First case of Omicron coronavirus variant identified in the U.S.